Agency 100 2019: Cambridge BioMarketing
Cambridge BioMarketing (CBM) underwent a year of change in 2018.
Cambridge BioMarketing (CBM) underwent a year of change in 2018.
The company’s revenue surged 29.2% in 2018, from an MM&M-estimated $32.5 million to an estimated $42 million.
MM&M editor-in-chief Steve Madden explains how a labor of love, or rather labor of logistics, culminates in the comprehensive guide to medical marketing.
The agency’s people roamed the area around the Palais during Lions Health, popping up with solutions to a host of Cannes-related “maladies,” and creating positive brand awareness.
Here are three of the campaigns most frequently mentioned by agency CEOs, directors and presidents. In other words, the work the industry’s leaders are talking about.
Horizon describes the Gout Lies website and campaign as “a mix of provocative visuals, expert videos and clinical data.”
More than just lip service, diversity and inclusion efforts are the right things to do, for everyone.
Steve Madden makes the case for the value of having awkward conversations about diversity, race and inclusion.
The Senate may not take up a confirmation vote before the 2020 election, but one Beltway insider predicts the FDA will still be potent during the transition to a new commissioner.
Levy, whose hire is effective on Wednesday, will be based in the agency’s New York City office.